FRA:OBCK • DE000BCK2223
The current stock price of OBCK.DE is 55.2 EUR. In the past month the price decreased by -10.02%.
ChartMill assigns a technical rating of 1 / 10 to OBCK.DE.
ChartMill assigns a fundamental rating of 3 / 10 to OBCK.DE. OBCK.DE has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months OBCK.DE reported a non-GAAP Earnings per Share(EPS) of 0.47. The EPS decreased by -38.36% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.88% | ||
| ROA | 1.49% | ||
| ROE | 13.19% | ||
| Debt/Equity | 4.45 |
12 analysts have analysed OBCK.DE and the average price target is 88.4 EUR. This implies a price increase of 60.14% is expected in the next year compared to the current price of 55.2.
For the next year, analysts expect an EPS growth of 455.04% and a revenue growth 6.01% for OBCK.DE
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1MDT | MEDTRONIC PLC | 16.09 | 108.279B | ||
| 2M6 | MEDTRONIC PLC | 15.58 | 104.868B | ||
| SHL | SIEMENS HEALTHINEERS AG | 15.83 | 47.083B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 17.53 | 25.681B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 17.55 | 25.614B | ||
| BIM | BIOMERIEUX | 19.23 | 11.321B | ||
| DIA | DIASORIN SPA | 17.31 | 3.975B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 11.42 | 2.367B | ||
| 1AFX | CARL ZEISS MEDITEC AG - BR | 10.94 | 2.309B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
Ottobock SE & Co. KGaA engages in the research, development, manufacture, and distribution of medical technology products. The company is headquartered in Duderstadt, Niedersachsen. The company went IPO on 2025-10-09. The firm develops and distributes medical technology products and services in the fields of prosthetics, neuro-orthotics, and exoskeletons. The firm operates patient care clinics and provides solutions for individuals with limited mobility. The company engages in research and development of human bionics and maintains a global presence through subsidiaries and partnerships in multiple countries.
OTTOBOCK SE & CO KGAA
Max-Naeder-Strasse 15
Duderstadt NIEDERSACHSEN DE
Employees: 0
Phone: 4955278480
Ottobock SE & Co. KGaA engages in the research, development, manufacture, and distribution of medical technology products. The company is headquartered in Duderstadt, Niedersachsen. The company went IPO on 2025-10-09. The firm develops and distributes medical technology products and services in the fields of prosthetics, neuro-orthotics, and exoskeletons. The firm operates patient care clinics and provides solutions for individuals with limited mobility. The company engages in research and development of human bionics and maintains a global presence through subsidiaries and partnerships in multiple countries.
The current stock price of OBCK.DE is 55.2 EUR. The price increased by 0.82% in the last trading session.
OBCK.DE does not pay a dividend.
OBCK.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
OBCK.DE stock is listed on the Frankfurt Stock Exchange exchange.
OTTOBOCK SE & CO KGAA (OBCK.DE) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on OBCK.DE.